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Abstract: Tissue engineered heart muscle may be able to
provide a treatment modality for early stage congestive
heart failure. In this study, we describe a new method to
engineer functional 3-dimensional heart muscle utilizing a
biodegradable fibrin gel. Primary cardiac myocytes were iso-
lated from hearts of 2- to 3-day-old rats and processed in
one of the two ways. For the first method (layering ap-
proach), the cells were plated directly on the surface of a
fibrin gel-coated on polydimethylsiloxane (PDMS) surfaces.
The cells were cultured in growth media and the contractile
performance evaluated after formation of 3-dimensional tis-
sue constructs. For the second method (embedding ap-
proach), the cells were suspended with thrombin and plated
on 35 mm tissue culture surfaces coated with PDMS.
Fibrinogen was then added to the surface. Within 7 days af-
ter initial cell plating, a 3-dimensional tissue construct of
cells derived from primary heart tissue (termed bioengi-
neered heart muscle, BEHM) resulted for both approaches.
Histological evaluation showed the presence of uniformly
distributed cardiac cells throughout the BEHM, both in lon-
gitudinal and cross sections. The stimulated active force of
BEHMs formed using the layering approach was 835.5 6
57.2 mN (N ¼ 6) and 145.3 6 44.9 mN (N ¼ 6) using the
embedding approach. The stimulated active force was de-
pendent on the initial plating density. It was possible to
maintain the contractile function of BEHM in culture for up
to 2 months with daily medium changes. The BEHMs exhib-
ited inotropy in response to external calcium and isoprotere-
nol and could be electrically paced at frequencies of 1–7 Hz.
We describe a novel method to engineer contractile 3-dimen-
sional cardiac tissue construct with a fourfold increase spe-
cific force compared to our previous model.  2006 Wiley
Periodicals, Inc. J Biomed Mater Res 80A: 719–731, 2007
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INTRODUCTION
Tissue engineering is based on the assumption that
patient-derived cells can be expanded in culture with-
out loss of differentiated phenotype to form functional
3-dimensional tissue constructs.1,2 Patient-derived
primary cells can be engineered to form functional 3-
dimensional cardiac muscle in the presence of the
appropriate electro-mechanical and chemical interven-
tions. Such tissue engineering methodology could be
utilized in translating 2-dimensional monolayer cell
cultures to more physiological 3-dimensional tissue
engineered constructs. Potential applications for 3-di-
mensional tissue engineered constructs would be in
high throughput drug screening and clinically as
patches to augment failing myocardial function.3
There have been several strategies utilized to
engineer cardiac tissue in vitro. Synthetic scaffolds,4
biodegradable gels,5–7 and self organization strategies8
have all been evaluated. Biodegradable gels were the
first model utilized to engineer functional 3-dimen-
sional heart muscle in vitro.9 Eschenhagen developed
a 3-dimensional model of tissue engineered heart
muscle by culturing chick cardiac myocytes in a colla-
gen matrix.9 The initial model was refined to generate
engineered heart tissue (EHT) by casting a mixture of
neonatal cardiac myocytes and collagen into plastic
molds.10 The EHTs were capable of generating a
stimulated active force of up to 500 mN10 and exhib-
ited several physiologically (contractile, histological,
and biochemical) metrics of heart function.10 Carrier
et al. were the first to demonstrate the feasibility of
utilizing polymeric scaffolds for cardiac tissue engi-
neering application.4 They utilized fibrous meshes
made from polyglycolic acid as a scaffolding material
for culturing neonatal cardiac myocytes.4 Okano devel-
oped sheets of cardiac cells in the absence of any
synthetic scaffolding material to promote the formation
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of functional 3-dimensional cardiac muscle in vitro.11,12
Temperature sensitive surfaces have been used to
manufacture 2-dimensional sheets of cardiac myo-
cytes.13–16 These sheets have been stacked together
to form 3-dimensional cardiac muscle.15
Our previous work has focused on promoting the
self organization of primary cardiac cells to form
contractile 3-dimensional heart muscle (cardioids)
in vitro.8 Cardioids were formed from the spontaneous
delamination of a confluent monolayer of neonatal
cardiac myocytes.8 Cardioid formation was dependent
on the self-organization of individual cardiac cells into
a 3-dimensional tissue construct.8 This process elimi-
nated the need for synthetic scaffolding material in
the contractile region of the tissue construct. Our ini-
tial work demonstrated the feasibility of utilizing self-
organization strategies to engineer functional heart
muscle in vitro. Recently, we have evaluated the use
of a biodegradable fibrin gel to promote the formation
of 3-dimensional tissue constructs.17 The major ad-
vantage of utilizing fibrin gel is the easily controllable
degradable kinetics and the rate of fibrin degradation
can easily be matched with the formation of new tis-
sue. We have successfully used this strategy to engi-
neer contractile skeletal muscle tissue in vitro.17
The current state of the art in cardiac tissue engi-
neering allows the formation of 3-dimensional
patches of heart muscle utilizing hydrogels, poly-
meric scaffolds, and self organization strategies. It
would be interesting to compare these three different
strategies. Self organization strategies have the
advantage of stimulating cardiac cells to generate
their own extracellular matrix components, whereas
hydrogels replicate the cardiac ECM with commer-
cially purified sources. However, the major limita-
tion of both these strategies is that the resulting con-
structs often lack the mechanical strength required
to sustain physiological conditions. Polymeric scaf-
folds satisfy the requirement of providing a closely
match and easily controllable mechanical environ-
ment for cardiac tissue constructs. Scaffolds also
offer the advantage of customized patches and pro-
vide an opportunity to engineer bioartificial ven-
tricles, which would be more challenging with
hydrogels and self organization methods.
We believe that each strategy offers several advan-
tages towards engineering functional 3-dimensional
heart muscle in vitro. Our laboratory is focused on
engineering functional heart muscle utilizing three
different strategies (self organization, hydrogels and
scaffolding) and understanding the unique features
of each model.
In this study, we were interested in evaluating the
feasibility of utilizing a rapidly degrading fibrin gel
to engineer functional cardiac muscle in vitro. The
objective of this study was to evaluate the feasibility
of utilizing fibrin gel as a support matrix to promote
the formation of 3-dimensional heart muscle. We des-
cribe methodology for the formation of bioengineered
heart muscle and metrics of myocardial performance
of the resulting tissue engineered construct.
METHODS
NIH guidelines for the care and use of laboratory ani-
mals (NIH Publication no. 85-23 Rev. 1985) have been
observed. All materials were purchased from Sigma (St.
Louis, MO) unless otherwise specified.
Isolation of neonatal cardiac myocytes
Cardiac myocytes were isolated from 2- to 3-day-old F344
rat hearts using an established method.18 Hearts were cut
into fine pieces and suspended in a dissociation solution
(DS) that consisted of 0.32 mg/mL collagenase type II (Wor-
thington Biochemical Corporation, Lakewood, NJ) and
0.6 mg/mL pancreatin dissolved in a buffer consisting of
116 mM NaCl, 20 mM HEPES, 1 mM Na2HPO4, 5.5 mM
glucose, 5.4 mM KCl, and 0.8 mM MgSO4. Digestion was
carried out in an orbital shaker for 5 min at 378C, after
which the supernatant was replaced with fresh DS and the
digestion process was continued for an additional 30 min.
At the end of the digestion process, the supernatant was col-
lected in 5 mL of horse serum (Invitrogen Corporation,
Auckland, New Zealand), centrifuged at 1500 rpm for 5 min
and the cell pellet was resuspended in 5 mL horse serum.
Fresh DS was added to the original, undigested tissue and
the digestion process was repeated an additional 2–3 times.
Cells from all the digests were pooled, centrifuged, and then
suspended in culture medium (CM) consisting of 320 mL
M199, 100 mL F12k, 50 mL fetal bovine serum, 25 mL horse
serum, 5 mL antibiotic-antimycotic (Invitrogen Corporation),
hydrocortisone 40 ng/mL, and insulin 100 ng/mL.
Preparation of the plates
The detailed method for preparing the culture surface
for engineering skeletal muscle has been described in
detail.17,19 This procedure was modified to engineer car-
diac muscle.8 Briefly, 35-mm culture plates were coated
with 1.5 mL of a polydimethylsiloxane (PDMS) elastomer
(Dow Chemical Corporation, Midland, MI). Anchor points
were 6-mm long segments of size 0 braided silk sutures
(Ethicon, Cornelia, GA) pinned 12 mm apart in the center
of the culture surface.
Formation of fibrin gel and cell plating
For layering approach, 0.5 mL of CM containing 10 U/mL
thrombin were plated on the surface of 35-mm cell culture
plates coated with SYLGARD (PDMS, type 184 silicone
elastomer) [Fig. 1(A)]. After this, 200 mL of 20 mg/mL fibri-
nogen was added to the 35-mm plate. The solution was
mixed to promote the formation of a fibrin gel within 10–
15 min. Primary cardiac cells were diluted in CM at varying
densities (0.5, 1, 2, and 4 millions/plate) and plated in 1 mL
of CM for each plate after complete gel formation.
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For the embedding approach, cells were suspended in
0.5 mL medium containing 10 U/mL thrombin and plated
on the surface of 35-mm cell culture plate coated with
SYLGARD [Fig. 1(B)]. Following cell plating, 200 mL of
20 mg/mL fibrinogen was added to the plate. The solution
on the surface of each plate was gently mixed by lateral
agitation, promoting the formation of a fibrin gel within
10–15 min. After complete gel formation, 1 mL of CM was
added to each plate.
The cells were cultured in an incubator at 378C and 5%
CO2 with medium changes every second day.
Evaluation of contractility
The method for evaluating the contractility of engi-
neered skeletal and cardiac muscle has been described in
detail.8 This method was modified slightly. Briefly, the
bioengineered heart muscle (BEHM) was placed in CM at
378C between parallel platinum electrodes. One end was
fixed to the plate and the other end was attached to a
custom-built optical force transducer. Stimulated active
force (response to a single electrical impulse) measure-
ments were recorded at 15 V, with a frequency of 1 Hz
and a 10 ms pulse width. The length of each BEHM was
adjusted to obtain maximum stimulated active force using
a multi-axis micromanipulator. This optimal length was
designated as Lo and was recorded. The cross-sectional
area of the BEHMs was calculated from the construct di-
ameter that was determined by a calibrated eyepiece reti-
cle with a resolution of 5 mm. The construct was assumed
to be cylindrical for this calculation. The specific force
(kN/m2) of each BEHM was determined by normalizing
the stimulated twitch force to the total cross-sectional area.
Figure 1. Methodology for the formation of bioengineered heart muscle (BEHM). A: Layering approach. Tissue culture
plates are coated with PDMS followed by thrombin and then fibrinogen. Neonatal cardiac myocytes are then plated on
the surface of the fibrin gel. B: Embedding approach. Neonatal cardiac myocytes are mixed with fibrinogen and then
thrombin. The cell suspension is then plated on the PDMS surface. In both cases, the spontaneous contractility of the neo-
natal cardiac myocytes results in delamination of the cell monolayer. Delamination initiates at the periphery of the culture
and progresses towards the center of the culture surface. The cell monolayer attaches to anchor points that have previ-
ously been placed at the center of the culture surface.
TISSUE ENGINEERED HEART MUSCLE 721
Journal of Biomedical Materials Research Part A DOI 10.1002/jbm.a
Initial stimulation parameters were selected based on
our previous experience with engineered cardiac muscle
constructs. The stimulation parameters had been optimized
for this system in pilot experiments. The BEHM was elec-
trically paced at frequencies between 1 and 7 Hz, with all
other stimulation parameters remaining constant.
The effect of the addition of calcium on contractility was
investigated in six constructs. For this part of the testing,
the constructs had been in culture for 7 days after initial
cell plating. The constructs were only used to evaluate the
calcium sensitivity with no additional testing being per-
formed. First, CM in the bath was replaced with calcium-
free Tyrode’s solution. Known volumes of 100 mM ethyl-
ene glycol-bis(2-aminoethylether)-N,N,N0,N0-tetraacetic acid
(EGTA) were then added to the bath to bind residual
stores of calcium in the constructs. At each incremental
addition of EGTA, twitch stimulation was applied and the
stimulated active force of contraction was measured. Re-
moval of calcium was considered to be complete when the
stimulated active force of contraction was not detectable
and no further EGTA was added. At this point, the cal-
cium-free DMEM in the bath was aspirated and the con-
struct was washed three times with fresh calcium-free
DMEM. Known volumes of 100 mM calcium were then
added and stimulated active forces were re-evaluated with
each addition. This process was repeated until there was
no further increase in the stimulated active force with the
addition of calcium. For each construct, the stimulated
active force was normalized to the maximum stimulated
active force generated for the particular construct. An av-
erage normalized value was obtained for the six constructs
and plotted against the calcium concentration.
The response to isoproterenol was studied in six con-
structs by adding known concentrations of isoproterenol to
the Tyrode’s solution in the presence of 100 mM calcium
(ED50, effective dose for 50% of the maximum twitch force
from previous calcium study), with the constructs still
attached to the force transducer. We evaluated the stimu-
lated active force after each incremental addition of isopro-
terenol. Once again, the stimulated active force was nor-
malized to the maximum stimulated active force generated
for the particular construct and an average normalized
value plotted against the isoproterenol concentration.
Histology
Following force testing, constructs were fixed in 4% para-
formaldehyde for 4 h and stored in 70% ethanol. The con-
structs were prepared in an automated tissue processor
(Shandon Hypercenter XP, Thermo Electron, Waltham, MA)
and then paraffin embedded. Seven micron sections were
cut and placed on Probeon Plus slides (Fisher Scientific
Company, Pittsburg, PA). Hematoxylin and eosin (H&E)
staining was used for morphologic analysis of the constructs.
Immunohistochemistry
Samples (whole hearts and BEHMs) were washed
with 1 DPBS 3 min and placed into a 10% formaldehyde
solution for 1 h. Samples were then washed with 1 DPBS
for 3 h and placed in 30% sucrose overnight. Samples
were dried and placed in a plastic peel-away container
filled with OCT compound and frozen on dry ice,
wrapped in parafilm, and stored at 808C until use. The
samples were sectioned at 10 mm using a cryostat set at
208C and kept frozen (808C) until ready for staining.
For immunohistochemistry, the sections were blocked with
a blocking solution containing 2% BSA, 2% normal goat se-
rum, 0.1% triton X-100, and 0.05% tween 20 for 1 h at
room temperature and then stained with the primary anti-
body for 1 h. The dilution ratios were as follows: 1:250 for
polyclonal anticollagen type I (Chemicon International,
Temecula, CA, Cat no. AB755P), 1:500 for monoclonal anti-
a-sacromeric actin (Sigma, St. Louis MO, Cat no. A2172),
1:50 for connexin43 (Chemicon International, Temecula,
CA, Cat no. AB1727) and 1:50 for monoclonal anti-N-cad-
herin/A-CAM clone GC-4 (Sigma, St Louis, MO, Cat no.
C3865). The sections were then washed with 1 DPBS
three times for 5 min and then incubated with secondary
antibody for 30 min in the dark. For the secondary anti-
bodies, we used anti-mouse secondary IgG FITC conjugate
(Sigma, St Louis, MO, Cat no. F5262) at a 1:150 dilution in
1 DPBS for anti-N-cadherin and anti-a-sacromeric actin
and anti-rabbit secondary Cy3 conjugated (Chemicon Inter-
national, Temecular, CA, Cat no. AP132C) at a dilution of
1:250 in DPBS for anticollagen type I and anticonnexin43.
The sections were then washed with 1 DPBS three times
for 5 min and air dried. A few drops of prolong gold anti-
fade reagent with DAPI (Molecular Probes, Eugene, OR)
were then added to the sections, which are covered with a
coverslip prior to viewing.
Statistical analysis
We used one way ANOVAs combined with the Tukey’s
test for all pair-wise comparisons. Minitab V13.31 (State
College, PA) was used for statistical analysis.
RESULTS
We engineered 3-dimensional heart muscle utilizing
both the layering and the embedding strategies. There
was a 100% success rate for construct formation with
an excess of 50 constructs formed by each method.
There were several notable methodology differen-
ces during BEHMs formation between the two dif-
ferent approaches. We observed differences in the
degree of cell spreading utilizing the embedding
approach versus the layering approach. When the
cardiac cells were embedded in the fibrin gel, there
was a significantly lower degree of cell spreading as
compared to cardiac cells plated on the surface of
the fibrin gel.
We also observed differences in the degree of
spontaneous contractility of the cell monolayer prior
to the formation of a 3-dimensional construct. Within
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48 h after initial cell plating, we were able to observe
spontaneous contractions of the cell monolayer in
the layering approach. The rate of spontaneous con-
tractions of the cell monolayer was in the order of
1–2 Hz and was very regular and consistent for the
duration of cell culture. In contrast, we only
observed the spontaneous contractions of clusters of
cardiac cells trapped in fibrin gel for the embedding
approach. These clusters of cardiac cells were uni-
formly distributed throughout the fibrin gel.
Although we observed differences in monolayer
contraction and degree of cell spreading, there were
no notable differences during compaction of the
fibrin gel between the two approaches. Within 3–
5 days after initial cell plating, we observed compac-
tion of the cell–gel construct for both approaches.
Compaction of fibrin gels was initiated at the periph-
ery of the culture surface due to the traction force
from cells and the degradation of the fibrin gel
[Fig. 2(A)]. This process continued to progress
towards the center of the culture surface and was
aided by the spontaneous contractions of the cardiac
myocytes [Fig. 2(B)]. At the center of the plate, the
cell–gel constructs attached to the anchor points that
were previously pinned into the center of the culture
plate [Fig. 2(C)]. The basal tension was maintained
between both sutures resulting in the formation of a
3-dimensional heart muscle construct, which we
have termed bioengineered heart muscle (BEHM)
[Fig. 2(C)].
We evaluated the effect of cell density on the con-
tractile performance of BEHM formed by the embed-
Figure 2. Various stages of formation of bioengineered heart muscle. Within 3 days after plating, the neonatal cardiac
myocytes initiate spontaneous contractility. The contractility of the cell monolayer initiates delamination (arrows) of the
fibrin gel from the underlying culture surface. Delamination is initiated at the (A) periphery of the culture surface and
progresses towards the (B) center of the culture surface. (C) After complete formation, the bioengineered heart muscle
(BEHM) is suspended between anchor points that have been pinned to the culture surface with 0.1 mm pins. [Color figure
can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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ding approach as well as the layering approach
(Fig. 3). The stimulated active force for constructs
formed by the embedding approach was found to be
in the range of 102–220 mN [Fig. 3(A)], whereas the
stimulated active force for constructs formed by the
layering approach was found to be in the range of
36–923 mN [Fig. 3(B)]. We found that there was no
significant change in the contractile performance of
Figure 3. Effect of cell density on the functional performance of BEHM. A: Embedding approach. Varying cell numbers
were suspended in a fibrin gel and utilized to form BEHM. We utilized cell numbers of 0.5, 1.0, and 2.0  106 cells per
plate. As controls, we utilized the layering approach for BEHM formation with a plating density of 0.5  106 cells per
plate. * denotes a statistical significant difference from controls with p < 0.05. There was no significant difference between
the three groups. B: Layering approach. We utilized plating density of 0.5, 1.0, 2.0, and 4.0  106 per plate. The stimulated
active force was evaluated within 48 h of BEHM formation. For each group N ¼ 6 BEHM. For every BEHM utilized utiliz-
ing both methods, we obtained 4 active contractions and used the average value for each BEHM. # denotes a statistical dif-
ference from the 0.5 and 1.0 group for the layering approach with p < 0.05. There was no significant difference between
the 0.5 and 1.0 group as well as the 2.0 and 4.0 group for the layering approach.
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BEHMs formed by the embedding approach utiliz-
ing a cell density of 0.5  106–2.0  106 cells per
plate [Fig. 3(A)]. In the case of BEHMs formed using
the layering approach, lower plating density resulted
in a higher contractile performance [Fig. 3(B)]. We
obtained the maximum stimulated active force of
812.3 6 54.2 mN utilizing a plating density of 0.5 
106–1.0  106 cells per plate for the layering
approach. There was a significant decrease in the
stimulated active force of the BEHM when the plat-
ing density was increased beyond 1.0  106 cells per
plate [Fig. 3(B)]. We also obtained a significant
decrease in the stimulated active force of BEHM
formed using a plating density lower than 0.5  106
cells per plate for the layering approach (data not
shown).
Based on our findings that BEHMs formed by the
layering approach generated significantly higher
forces than BEHMs formed by the embedding
approach, we decided to proceed with further inves-
tigation using the former (layering) approach.
We evaluated the changes in contractile perform-
ance of BEHM over time in culture (Fig. 4). Utilizing
a plating density of 1  106 cells/construct, we
found that the BEHMs were able to maintain con-
tractile performance over a period of 12 days, after
which time we observed a significant drop in the
stimulated active force. In subsequent experiments,
we were able to maintain the ability to generate
stimulated active force of the BEHM with daily me-
dium changes for a period of up to 2 months (data
not shown). During long-term culture of BEHM,
there was a significant decrease in the diameter of
the construct over time. At the time of formation (4–
5 days), the diameter of the BEHM was larger than
500 mM. After one week in culture, the diameter
decreased to 200–300 mM, and to an average value of
150–250 mM after 2 weeks in culture. We calculated
the specific force of the constructs by normalizing
the stimulated active force to the total cross-sectional
area. At the time of formation, the specific force of
the constructs was found to be 2–4 kN/m2. After
2 weeks in culture, though the absolute force did not
increase, the specific force increased to 12–15 kN/m2
due to the decrease in cross sectional area of the
BEHM, and the specific force was maintained for the
duration of the culture.
We also evaluated the changes in passive force of
the BEHMs over time and found that the average
passive force was 100–200 mN and did not change
significantly over time. The passive force was due to
the baseline activity of the cells while fibrin degrada-
tion did not significantly influence the passive force.
Therefore, the passive force did not change signifi-
cantly over time, during which period there was
degradation of the fibrin gels.
Hematoxylin and eosin staining was utilized to
study the rate of fibrin degradation as well as
the cellular distribution within the 3-dimensional
BEHM. At the time of formation, greater than 50%
of the construct volume was occupied by the fibrin
gel [Fig. 5(A)]. During culture, the fibrin gel was
Figure 4. Changes in contractile performance of BEHM in culture. We evaluated the stimulated active force of BEHM
that was formed using the layering approach with a plating density of 1  106 cells/constructs at 4, 6, 8, 12, 17, and 21
days after complete formation. For each group, N ¼ 6 BEHMs and for each BEHMs we use an average of 4 twitches. There
was no statistical difference between the stimulated active force at 4, 6, 8, and 12 days. # denotes a significant difference
with 4, 6, 8, and 12 day BEHM. @ denotes no significant difference with 17 day BEHM. For all cases, p < 0.05).
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degraded by the cardiac cells, which resulted in a
smaller volume of the BEHM being occupied by the
cells. A significant percentage of the fibrin was
degraded within 7 days and there was virtually no
fibrin visible by day 14 [Fig. 5(B)]. The total volume
of engineered heart muscle constructs was reduced
from initial 700 mm3 (0.7 mL fibrin gel) to 0.4 mm3
(200 mm diameter of 12-mm constructs) after 2-week
culture.
The cardiac cells were uniformly distributed
throughout the BEHM. This was evident in both the
cross-section [Fig. 5(B)] as well as the longitudinal
section [Fig. 5(C)] of the BEHM. In the cross-section,
we observed a relatively uniform distribution of cells
throughout the BEHM. In addition, a very small
amount of fibrin was also evident. This was also the
case for the longitudinal section. The cardiac cells
were aligned along the length of the BEHM. The
degree of alignment was very regular throughout
the length of the construct.
We evaluated the distribution of collagen type I,
F-actin, connexin43, and N-cadherin in the cardioids
(Fig. 6). The collagen appeared to be present in an
early unpolymerized state with very little evidence
of well-formed fibers [Fig. 6(E)]. The F-actin seemed
to be present in large amounts with longitudinally
aligned fibers visible [Fig. 6(F)]. Staining for connex-
xin43 [Fig. 6(G)] and N-cadherin [Fig. 6(H)] showed
the formation of electrical and mechanical coupling
points between adjacent cardiac myocytes.
We evaluated the pacing characteristics of the
BEHMs (Fig. 7) at frequencies of 1, 3, 5, and 7 Hz. At
the lower pacing frequencies, the BEHMs were able
to return to baseline force between active contrac-
tions. In addition, there were no signs of fatigue (as
evaluated by the size of successive contractions) and
we observed a direct correlation between the number
of electrical impulses and the number of stimulated
active contraction. At the higher frequencies (5 and
7 Hz), there was also a linear correlation between
electrical impulses and number of contractions with
no signs of fatigue. However, the constructs were not
able to return to baseline conditions between stimu-
lated active contractions at the higher frequencies.
We evaluated the responsiveness of the BEHM to
calcium (Fig. 8). In the absence of calcium or at very
low calcium concentrations, the BEHMs were not
able to generate measurable stimulated active force.
However, as the bath calcium concentration was
increased, we observed a near linear increase in the
stimulated active force. The stimulated active force
increased to 50% of maximal value at a calcium con-
centration of 100 mM (ED50) and 90% within the
range of 800–1200 mM. The pCa1/2, defined as the
negative log of the calcium concentration required to
generate half the maximal force, of our BEHMs was
found to be in the range of 4.0–4.2.
We also evaluated the effect of isoproterenol on
the contractility of BEHM (Fig. 9). We obtained a
dose-responsive increase in the stimulated active
force with increasing concentrations of isoproterenol
in the range of 1 nM to 50 nM. We obtained 50% of
the maximal stimulated active force at an isoprotere-
nol concentration of 1–5 nM and 90% at 50 nM.
Figure 5. Histological characterization of BEHM. A: The
constructs (made by the layering approach) were stained
with hematoxylin and eosin 2 days after complete forma-
tion. At 2 days, there was a significant amount of fibrin (F)
in the construct with scattered cardiac cells (single arrow).
For (B) and (C), the constructs were stained with hematox-
ylin and eosin 1 week after complete formation. B: Cross-
section shows the presence of uniformly distributed cells
throughout the 3-dimensional tissue construct. C: Longitu-
dinal section shows a very high degree of cellular align-
ment. In both cases, non degraded fibrin is visible (double
arrows). [Color figure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
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DISCUSSION
In this study, we evaluated two methods (layering
versus embedding) to promote the formation of func-
tional 3-dimensional BEHM. Initially, we utilized
fibrin gel as a support matrix to culture skeletal
muscle cells.17 We compared both the layering and
embedding approach and found that the layering
approach was more suitable to promote myotube
formation.17 Though we found the layering approach
Figure 6. Staining for Collagen type I, F-actin, connexxin43, and N-Cadherin. (A–D) Control hearts and (E–H) BEHMs.
All images were counterstained with DAPI to visualize the nucleus. For the control hearts, the DAPI image was overlayed
with the image for the specific protein. For the BEHMs, the DAPI image is shown separately as the proportion of the spe-
cific protein is considerable lower than the nuclear material. The BEHMs used for staining were formed via the layering
approach and maintained in culture for 7 days after complete formation. [Color figure can be viewed in the online issue,
which is available at www.interscience.wiley.com.]
Figure 7. Pacing characteristics of BEHM. The constructs were electrically paced at (A) 1 Hz, (B) 3 Hz, (C) 5 Hz, and
(D) 7 Hz. We utilized a voltage of 10 V and a pulse width of 2 ms.
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to perform well with skeletal myoblasts, the embed-
ding approach seems to have been a preferred
model for other groups in the field.4,9 Therefore, we
were interested in comparing the two methods to
support the formation functional cardiac muscle
in vitro.
In the case of the embedding approach, primary
cardiac cells were suspended in thrombin solution
that had been plated on a tissue culture surface
were mixed with a fibrinogen solution. For the
layering strategy, the fibrin gel was layered on
the culture surface and then the cardiac cells were
plated on the surface of the fibrin gel. When the
cardiac cells are plated on the surface of the fibrin
gel, we observed very regular spontaneous contrac-
tions of the entire cell monolayer, initiating within
48 h after cell plating. The spontaneous contractions
of the constructs resembled the synchronous con-
tractions of the normal myocardium. The spontane-
ous contractions of the cohesive cell monolayer in
synchrony do provide some indirect support for the
formation of intercellular connections between adja-
cent cardiac myocytes as well as connections
between the cardiac cells and the fibrin gel. This
was not the case for BEHMs formed by the embed-
ding approach, in which case we observed isolated
patches of contractile tissue. We speculate that this
was likely due to the inability of the cardiac cells to
spread and form intercellular connections with
neighboring cells.
We found an interesting response of the BEHMs
with plating densities. When utilizing the embedding
approach, the plating density (0.5  106–2.0  106
cells/construct) did not affect the stimulated active
force production of the constructs. We speculate
this was due to the limited cell spreading ability
within the fibrin gel. However, when we utilized
the layering approach, we found that lower plat-
ing densities (0.5  106–1.0  106 cells/construct)
resulting in constructs that generated significantly
higher forces than constructs formed with higher
plating densities (2.0  106–4.0  106 cells/con-
struct). We believe that our static in vitro cell cul-
ture system is not able to support the viability of
larger cell numbers, therefore resulting in lower
functional performance. As efficient perfusion sys-
tems are developed, there may be a reversal of this
trend.
There have been several models described in the
literature and the contractile properties of EHT
have been described in detail.9,20 EHTs are gener-
ated by casting a suspension of cardiomyocytes in
a collagen gel.20 EHTs have been shown to gener-
ate a stimulated active force of 350 mN with a spe-
cific force of 0.4 kN/m2 under basal conditions.20
In comparison, BEHMs have been shown to gener-
Figure 8. Calcium sensitivity of BEHM. The constructs were placed in a calcium-free DMEM. Calcium was gradually
added back to the bath by introducing incremental volumes of 100 mM calcium. The bath concentration of calcium
was varied from 50 to 2000 mM. The stimulated active force of contraction was evaluated at each calcium concentration.
The stimulated active force at each calcium concentration was normalized to the maximum stimulated active force
obtained for the construct. This process was repeated for a total of 6 constructs. The values plotted are the average and
standard deviation for the 6 constructs tested. * denotes significant difference in the average stimulated active force at
the specified calcium concentration than the average stimulated active force at the previous calcium concentration at
p < 0.05).
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ate stimulated active force in the order of 800 mN
and a specific force of 15 kN/m2. BEHMs are
capable of generating considerably higher active
forces under basal conditions than EHTs. We spec-
ulate that this is due to a high degree of cellular
alignment and compaction without excess extracel-
lular matrixes in the BEHMs after fibrin degrada-
tion. The passive tension maintained between the
suture materials promotes the alignment of the
cardiac cells during BEHM formation, as evident
in the histology. In contrast, the EHTs are formed
by casting a mixture of cardiac cells with collagen
gel. The final EHTs still have a lot of collagen sur-
rounding, which results in large diameter and low
specific force.
The specific force of native very thin cardiac
muscle preparations is between 20 and 45 kN/m2
and is dependent on frequency.21 For example, the
contractile performance of adult rat papillary
muscle has been shown to be in the order of
8130 mN for the stimulated active force and a spe-
cific force of 44.4 kN/m2.22 In comparison to these
published values, our BEHMs generate consider-
able lower specific forces. The maximum specific
force generated by BEHMs is in the order of
15 kN/m2 at the time of complete fibrin degrada-
tion. Understanding and optimizing BEHM forma-
tion will help bridge the gap between the contract-
ile performance of BEHM and normal myocardial
tissue.
Self-organized heart muscle (cardioids) have been
shown to generate a stimulated active force of 75–
125 mN at the time of formation for a specific force
of 2.4–4.0 kN/m2.8 Clearly, BEHMs generate more
stimulated active force than cardioids. We speculate
that the fibrin gel simulates a temporary extracellu-
lar matrix allowing functional organization of the
cardiac cells. Cardioids are self organized from iso-
late primary cardiac myocytes and fibroblasts.8
Although the cardiac fibroblast generate extracellu-
lar matrix to support 3-dimensional tissue forma-
tion, the degree of cellular organization may not be
optimal. This in turn may result in lower active
force production.
Histological data provided evidence for some
degree of functional coupling between adjacent car-
diac myocytes. There was positive staining for con-
nexxin43 and N-cadherin that shows some degree
of cellular coupling. There was also positive stain-
ing for collagen type I and F-actin, showing some
degree of tissue level organization of the isolated
cardiac cells. Comparison of the BEHM images with
those of control hearts provides a clear picture of
where we are with the current model and where
we need to go. There is still a significant amount of
work that needs to be done to bridge the gap
Figure 9. Effect of isoproterenol on BEHM. The constructs were placed in calcium free DMEM. The bath calcium concen-
tration was adjusted to 100 mM by the addition of external calcium. The concentration of isoproterenol was increased from
1 to 50 nM and the stimulated active force evaluated at every incremental addition. The stimulated active force was nor-
malized to the stimulated active force obtained for the construct. This process was repeated for a total of 6 constructs. The
values plotted are the average and standard deviation for the 6 constructs tested. * denotes a significant difference from
control (no isoproterenol) with p < 0.05. # denotes no change in stimulated active force production from previous isopro-
terenol concentration).
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between tissue engineered constructs and normal
heart tissue. This is somewhat expected as our
tissue engineering models are still in a premature
state of development.
In addition to the stimulated active force, we
evaluated the pacing characteristics of the BEHM
as well as the responsiveness to ionic calcium and
isoproterenol. The responsiveness of the BEHM to
calcium shows the presence of a functional cal-
cium handling cascade and provides further sup-
port for the formation of functional viable heart
muscle. The pCa1/2 of the BEHMs was found to
be in the range of 4.0–4.2. The pCa1/2 of mamma-
lian cardiac tissue has been reported in the range
5.9 to 7.0.23 Our constructs, therefore, exhibit a
decreased sensitivity to calcium versus normal
cardiac tissue. This could be due to the lack for a
well-organized tissue level architecture of the
BEHMs, resulting in suboptimal calcium handling
properties.
The responsiveness to isoproterenol also lends
support to the functional organization of cardiac
cells. Isoproterenol has been shown to result in a
doubling of the active force production at a concen-
tration of 30 mM in rabbit ventricular muscle.24 In
our BEHMs, we obtained a maximal response at a
much lower isoproterenol concentration (50 nM),
providing evidence of the presence of b-adrenergic
receptors, an important physiological response of
cardiac muscle.
Collectively, these performance metrics provide
direct support for the functional organization of the
cardiac cells into cardiac tissue in the BEHM.
The ability to electrically pace the construct
shows some degree of cardiac phenotype and for-
mation of functionally viable 3-dimensional heart
muscle. The constructs were able to return to base-
line force at the lower pacing frequencies of 1 and
2 Hz. However, at 5 and 7 Hz, we observed that
the constructs were not able to return to baseline
conditions. We believe that the reason for this is a
lack of complete tissue level organization of cellu-
lar and extracellular components within the 3-
dimensional architecture of the BEHMs. This
potentially results in slower calcium transients,
thereby limiting the number of active contractions
per unit time, possibly due to a lower expression
of SERCA.
We believe that the current model adds value to
the field of cardiac tissue engineering by presenting
a novel way to engineer 3-dimensional heart muscle
in vitro. Fibrin has several characteristics that make
this suitable to support the formation of cardiac
patches and we believe that this works adds to the
current literature on cardiac tissue engineering. Our
current work demonstrates that cardiac patches gen-
erated utilizing fibrin have contractile performance
comparable to other published models of 3-dimen-
sional heart muscle in vitro.
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